Angelo Avogaro to United States Food and Drug Administration
This is a "connection" page, showing publications Angelo Avogaro has written about United States Food and Drug Administration.
Connection Strength
0.099
-
SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System. Lancet Diabetes Endocrinol. 2017 09; 5(9):680-681.
Score: 0.099
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.